The Addition of Salmeterol 50 µg Bid to Anticholinergenic Treatment in Patients with COPD: A Randomized Placebo Controlled Trial
oleh: Kenneth R Chapman, Peter Arvidsson, AG Chuchalin, DP Dhillon, Peter Faurschou, Roger S Goldstein, AF Kuipers
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2002-01-01 |
Deskripsi
BACKGROUND: In the past, the role of long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD) relative to other agents has been unclear.